ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,255.20
1.29%
Dow Jones
40,415.44
0.32%
Brent Oil
81.535
0.02%
Bitcoin
67,636.65
0.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Hvivo Plc (HVO) Quote

Hvivo Plc

Hvivo Plc (HVO)

LSE
30.60
0.10
(0.33%)
Closed July 22 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
30.60
Bid
30.20
Ask
31.00
Volume
1,669,974
30.60 Day's Range 30.60
15.35 52 Week Range 31.00
Market Cap
207.513M
Previous Close
30.50
Open
30.60
Last Trade
297840
@
30.9
(O)
Last Trade Time
Financial Volume
511,012p
VWAP
30.60
Average Volume (3m)
2,223,957
Shares Outstanding
680,371,877
Dividend Yield
0.65%
PE Ratio
12.91
Earnings Per Share (EPS)
0.02
Revenue
56.04M
Net Profit
16.12M

About Hvivo Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.hvivo.com
Headquarters
London, Gbr
Founded
1970
Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 30.50p. Over the last year, Hvivo shares have traded in a share price range of 15.35p to 31.00p.

Hvivo currently has 680,371,877 shares outstanding. The market capitalization of Hvivo is £207.51 million. Hvivo has a price to earnings ratio (PE ratio) of 12.91.

HVO Latest News

More News

hVIVO reports 31% revenue jump; relocation to improve efficiencies

hVIVO PLC on Wednesday reported strong revenue growth and a positive outlook amid its move to a new facility in Canar ...

July 17 2024
Alliance News

hVIVO PLC Holding(s) in Company

hVIVO PLC 17 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name HVIVO PLC UK or Non-UK Issuer UK 2. Reason for Notification An...

July 17 2024
RNS Regulatory News

hVIVO PLC Trading update

hVIVO PLC 17 July 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Trading update Record H1 revenue and EBITDA margin   hVIVO plc (AIM & Euronext: HVO), a fast-growing specialist...

July 17 2024
RNS Regulatory News

hVIVO PLC Holding(s) in Company

hVIVO PLC 08 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name HVIVO PLC UK or Non-UK Issuer UK 2. Reason for Notification An...

July 08 2024
RNS Regulatory News

hVIVO PLC Holding(s) in Company

hVIVO PLC 03 July 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Holding(s) in Company   hVIVO plc (AIM & Euronext: HVO), a fast growing specialist contract research...

July 03 2024
RNS Regulatory News

TRADING UPDATES: Creo extends contract; Belluscura raises funds

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

July 02 2024
Alliance News

hVIVO PLC Change of registered address

hVIVO PLC 02 July 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Change of registered address   hVIVO plc (AIM & Euronext: HVO), a fast growing specialist contract research...

July 02 2024
RNS Regulatory News

hVIVO PLC Capital Markets Day & Notice of trading update

hVIVO PLC 02 July 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Capital Markets Event and Trading Update on 17 July   hVIVO plc (AIM & Euronext: HVO), a fast growing...

July 02 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.3512.293577981727.2530.7527.25458230828.94201647DE
43.3512.293577981727.2530.7526.9278785027.88740474DE
122.358.318584070828.2530.7526.1222395727.49409678DE
264.3516.571428571426.253124.75285599927.82225834DE
5215.0596.784565916415.553115.35258488024.70279941DE
1568.639.090909090922318.565204561820.09053827DE
26023.13087.547.254.55275228118.60946991DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.07M
CMAXCareMax Inc
$ 5.19
(228.48%)
102.64M
NUKKNukkleus Inc
$ 0.499
(55.94%)
26.19M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.87M
ONDSOndas Holdings Inc
$ 1.1297
(34.06%)
2.19M
LGCBLinkage Global Inc
$ 3.6601
(-29.82%)
168k
CGBSCrown LNG Holdings Ltd
$ 0.9997
(-29.10%)
3.38M
SPECSpectaire Holdings Inc
$ 0.3962
(-24.53%)
1.87M
GSUNGolden Sun Health Technology Group Ltd
$ 5.13
(-23.66%)
158.58k
PSNLPersonalis Inc
$ 2.9808
(-22.58%)
3.1M
NVDANVIDIA Corporation
$ 123.54
(4.76%)
238.89M
SQQQProShares UltraPro Short QQQ
$ 8.09
(-4.37%)
183.49M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.07M
SERVServe Robotics Inc
$ 8.73
(15.63%)
151.5M
NCPLNetcapital Inc
$ 0.1118
(7.50%)
124.27M

Discussion

View Full Feed
patrik patrik 3 minutes ago
W2R,
But there are some here expecting any day kaboom! I’m looking
at end of year or possibility early 2025
Patrik
KBLB
Stinger2014 Stinger2014 5 minutes ago
The good news, the MC can’t get much lower. I still believe the RS is already baked in.
CGAC
DesertDrifter DesertDrifter 5 minutes ago
Yep. I was just thinking out loud. Still not a lot of official stuff coming out about the Ear of Trump episode. No legit medical release that mentions any stitches, grafts, etc. the photos of him golfing without bandage the day after with no visible wounds seems still curious.
fuagf fuagf 5 minutes ago
Yep. It's a must do now after you've thrown that gauntlet down. https://www.democraticunderground.com/emoticons/toast.gif
LCJR LCJR 5 minutes ago
Volume seems correct. Not sure about the individual trades though.

LCJR
AAGC
somberfox somberfox 6 minutes ago
All of that experience, and here we are at near trip 0s with millions in dilution, a deal with your biggest partner gone in the wind and a month behind on an audit of nothing.

Hey, we're getting a watch though.
RONN
SSKILLZ1 SSKILLZ1 6 minutes ago
SSKMP Managed Index (As Of 7/22/24)

Daily Performance
-0.08%

YTD Performance
+5.20%

Overall Performance
+494.90% (Including Options Trading +358.88%)
ExtremelyBullishZig ExtremelyBullishZig 6 minutes ago
Cool! So he can bring the drug to market then? Or is he just better at making the science work...I am trying to figure this one out. Steady told us that no one's opinion matters...
AVXL
ddls ddls 7 minutes ago
Yes, let's get this-junk going, for the note-holders.

https://www.otcmarkets.com/otcapi/company/financial-report/397773/content
BIEL
janice shell janice shell 8 minutes ago
I've never even thought of making my own ketchup. And I've been eating Heinz all my life. I'm still alive. I don't use all that much of it, though. I use much more mayo.
Ashley250nelson Ashley250nelson 8 minutes ago
Trials starting next week!lfgo Jim saved us
GSTC
GMH* GMH* 8 minutes ago
The company themselves said that the dropout rate will decline over time, so I am going from that, but they also said it was in-line with trials. Also, note that the 5% drop was, I assume, from patient health decline. There was also a statement in the same article that the manufacturing success ra
IOVA
bigstocksnbonds bigstocksnbonds 9 minutes ago
YES SIR!!!!!
MasterBlastr MasterBlastr 9 minutes ago
Have to take advantage of the rules of the game, to make it fair.
bigstocksnbonds bigstocksnbonds 9 minutes ago
Awesome yes!!!!!
Real McCoy Real McCoy 9 minutes ago
If you are going to start the cycle by saying that some folks here are cruelly committed to not allowing complete lies and fantasies to sit unrefuted, I will gladly complete the cycle by noting you are also guilty of an equal committment to fight for the right to say you believe said lies and fantas
Scott 75 Scott 75 10 minutes ago
Hopefully not on a cold slab somewhere.
UATG
janice shell janice shell 10 minutes ago
Bobo is just so breathtakingly stupid.
BADALI BADALI 10 minutes ago
I am watching this week and will add if goes Lower.
HIRU
_-Abe-_ _-Abe-_ 10 minutes ago
Just remember. This company has a pile of back orders to fill and are now able to begin that process. I’m looking forward to Q4 numbers.
EOSE
Genz2 Genz2 11 minutes ago
https://www.theregister.com/AMP/2024/07/22/windows_crowdstrike_kernel_eu/

Why is Microsoft blaming the EU when it is apparent that they didn’t allow Wave on Windows 10 and 11? I think they allowed Crowdstrike on their platform because they knew that Clownstrike was inferior to Window
moosedogger moosedogger 11 minutes ago
"I won't sell for less than "60.00"

Prove that you really missed me! I think you are not only FOS but also suffer from excrement of the 11th magnitude clogging what used to be your brain.

You might be the saddest and mentally sickest creature on the iHub boards.
AUPH
irishintelligence irishintelligence 12 minutes ago
Who knows - it obviously does not matter. Nothing is stopping him from continuing to develop property.


http://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1dr223l-Anatomy%20of%20a%20Basher%20-%20Do%20and%20Don%27t.pdf

“Use 10% fact and 90% suggestion”

Fa
SPZI

Your Recent History

LSE
HVO
Hvivo
BIT
P1YMJ7
NLBNPIT1YMJ7 20991231 46...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved